GlassScriptPhysician profile
Elizabeth A Scheff
NPI 1114930880
$583.74
in general payments reported to CMS, 2019-2025
11 companies · $55.68 in 2025
The $55.68 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2020: $83.98 · 2021: $49.88 · 2022: $20.23 · 2023: $170 · 2024: $5.29 · 2025: $55.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $230.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $138.33 | 2019-2023 | Lo Loestrin Fe |
| Medtronic, INC. | $138.10 | 2023 | Interstim |
| Avion Pharmaceuticals | $100.88 | 2019-2021 | |
| Lsi Solutions INC | $55.68 | 2025 | Cor-Knot |
| Organon LLC | $39.76 | 2021-2024 | |
| Exeltis, USA INC. | $26.74 | 2019-2020 | |
| Hologic Sales and Service, LLC | $22.85 | 2021 | |
| Ethicon US, LLC | $19.79 | 2020 | |
| Coopersurgical, INC. | $17.74 | 2023 | Summit Doppler |
| Duchesnay USA Incorporated | $12.01 | 2019 | |
| Lupin INC. | $11.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Scheff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.